Weimin Liu

This inventor holds 46 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Samsung Electronics Co., Ltd., Boehringer Ingelheim International Gmbh. Active years: 2001-2025.

USPTO Granted Patents = 46 (Patent Applications = 4)

% Patents Active = 93.5

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 174(Granted Patents)

Location History:

Shelton, CT (US) (2001 - 2007)
Gansu, CN (2008)
Sandy Hook, CT (US) (2004 - 2020)
Beijing, CN (2009 - 2022)

Company Filing History:

21 out of 277

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

9 out of 132,107

Samsung Electronics Co., Ltd.

patents

8 out of 1,560

Boehringer Ingelheim International Gmbh

patents

4. 5 out of 49

Beijing Samsung Telecom R&d Center

patents

5. 4 out of 3,332

Chinese Academy of Sciences

patents

6. 2 out of 60

Aerie Pharmaceuticals, Inc.

patents

7. 1 out of 1

Lanzhou Institute of of Chemical Physics

patent

8. 1 out of 5

Shionogi Bioresearch Corporation

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Rho Kinase Inhibitors

Leukotriene Production Inhibitors

Amphiphilic Derivatives

OLEDs

Cysteine Protease Inhibitors

Network Feedback

Dual-Mode Access Terminal

Organic Compounds

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12406778 - Oil-soluble conductive additive and preparation method therefor (2025-09-02),

2. 11439707 - Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof (2022-09-13),

3. 11243087 - Device and method for providing content to user (2022-02-08),

4. 11154548 - Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof (2021-10-26),

5. 11092454 - Device and method for providing content to user (2021-08-17),

6. 10624882 - Rho kinase inhibitors (2020-04-21),

7. 9894134 - Method and device for obtaining network feedback (2018-02-13),

8. 8829200 - Benzimidazole inhibitors of leukotriene production (2014-09-09),

9. 8809326 - Isoquinolinone Rho kinase inhibitors (2014-08-19),

10. 8772304 - Benzimidazole inhibitors of leukotriene production (2014-07-08),

11. 8658661 - Oxadiazole inhibitors of leukotriene production (2014-02-25),

12. 8580829 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

13. 8580825 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

14. 8575201 - Oxadiazole inhibitors of leukotriene production (2013-11-05),

15. 8552205 - Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides (2013-10-08),

**Title: Inventor Weimin Liu**

Introduction:

Weimin Liu is a renowned inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Weimin Liu holds several patents in various technological domains, showcasing his continuous dedication to advancing the industry.

Career Highlights:

Throughout his illustrious career, Weimin Liu has demonstrated a remarkable ability to conceptualize and develop innovative solutions that have had a significant impact on the technological landscape.

Collaborations:

Weimin Liu has collaborated with leading industry experts and research institutions, further solidifying his reputation as a visionary inventor at the forefront of technological advancements.

Conclusion:

In conclusion, Weimin Liu's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventions, with a legacy that continues to inspire future generations of inventors.